Marc Guiu

1.7k total citations
20 papers, 848 citations indexed

About

Marc Guiu is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Marc Guiu has authored 20 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Marc Guiu's work include Bone health and treatments (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Marc Guiu is often cited by papers focused on Bone health and treatments (3 papers), Radiopharmaceutical Chemistry and Applications (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Marc Guiu collaborates with scholars based in Spain, France and United States. Marc Guiu's co-authors include Roger R. Gomis, Jelena Urosevic, M.L González Morales, Evarist Planet, Milica Pavlović, Anna Arnal Estape, Esther Fernández, Anna Bellmunt, Cristina Nadal and Joan Massagué and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Marc Guiu

19 papers receiving 838 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marc Guiu Spain 14 454 353 228 119 107 20 848
Hans Petter Eikesdal Norway 19 496 1.1× 412 1.2× 292 1.3× 98 0.8× 106 1.0× 41 987
Daniëlle Raats Netherlands 15 391 0.9× 325 0.9× 154 0.7× 158 1.3× 113 1.1× 28 818
Annett Linge Germany 15 445 1.0× 321 0.9× 238 1.0× 83 0.7× 160 1.5× 42 893
Jeremy McGuire United States 10 320 0.7× 188 0.5× 257 1.1× 74 0.6× 111 1.0× 20 740
Jinxiang Tan China 14 429 0.9× 208 0.6× 253 1.1× 60 0.5× 81 0.8× 21 818
Cuiju Tang China 14 382 0.8× 340 1.0× 178 0.8× 96 0.8× 240 2.2× 47 853
Dan G. Duda United States 5 259 0.6× 200 0.6× 143 0.6× 151 1.3× 55 0.5× 8 736
Yee Sun Tan United States 11 523 1.2× 222 0.6× 432 1.9× 201 1.7× 93 0.9× 16 981
Jinhui Liao United States 14 444 1.0× 415 1.2× 104 0.5× 122 1.0× 148 1.4× 22 872
Alessandra Boe Italy 21 693 1.5× 350 1.0× 412 1.8× 203 1.7× 87 0.8× 37 1.2k

Countries citing papers authored by Marc Guiu

Since Specialization
Citations

This map shows the geographic impact of Marc Guiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Guiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Guiu more than expected).

Fields of papers citing papers by Marc Guiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Guiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Guiu. The network helps show where Marc Guiu may publish in the future.

Co-authorship network of co-authors of Marc Guiu

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Guiu. A scholar is included among the top collaborators of Marc Guiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Guiu. Marc Guiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Martín-Martín, Natalia, Ianire Astobiza, Amaia Zabala‐Letona, et al.. (2024). The PP2A regulator IER5L supports prostate cancer progression. Cell Death and Disease. 15(7). 514–514. 1 indexed citations
2.
Rivas, Elisa, Jenniffer Linares, Melissa Zwick, et al.. (2022). Targeted immunotherapy against distinct cancer-associated fibroblasts overcomes treatment resistance in refractory HER2+ breast tumors. Nature Communications. 13(1). 5310–5310. 40 indexed citations
3.
Oliván, Mireia, Marta García, Marc Guiu, et al.. (2021). Loss of microRNA-135b Enhances Bone Metastasis in Prostate Cancer and Predicts Aggressiveness in Human Prostate Samples. Cancers. 13(24). 6202–6202. 11 indexed citations
4.
Guiu, Marc, et al.. (2021). In Vivo Assessment of Metastatic Cell Potential in Prostate Cancer. Methods in molecular biology. 2294. 253–267. 2 indexed citations
5.
Urosevic, Jelena, Maria Blasco, Anna Bellmunt, et al.. (2020). ERK1/2 Signaling Induces Upregulation of ANGPT2 and CXCR4 to Mediate Liver Metastasis in Colon Cancer. Cancer Research. 80(21). 4668–4680. 41 indexed citations
6.
Slebe, Felipe, Federico Rojo, María Vinaixa, et al.. (2016). FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth. Nature Communications. 7(1). 11199–11199. 43 indexed citations
7.
Urosevic, Jelena, Christina Mertens, Javier Mora, et al.. (2016). Tumour stroma‐derived lipocalin‐2 promotes breast cancer metastasis. The Journal of Pathology. 239(3). 274–285. 78 indexed citations
8.
Pavlović, Milica, Anna Arnal Estape, Federico Rojo, et al.. (2015). Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis. JNCI Journal of the National Cancer Institute. 107(12). djv256–djv256. 74 indexed citations
9.
Guiu, Marc, Enrique J. Arenas, Sylwia Gawrzak, Milica Pavlović, & Roger R. Gomis. (2015). Mammary Cancer Stem Cells Reinitiation Assessment at the Metastatic Niche: The Lung and Bone. Methods in molecular biology. 1293. 221–229.
10.
Oller‐Salvia, Benjamí, Macarena Sánchez‐Navarro, Sonia Ciudad, et al.. (2015). MiniAp‐4: A Venom‐Inspired Peptidomimetic for Brain Delivery. Angewandte Chemie International Edition. 55(2). 572–575. 78 indexed citations
11.
Oller‐Salvia, Benjamí, Macarena Sánchez‐Navarro, Sonia Ciudad, et al.. (2015). MiniAp‐4: A Venom‐Inspired Peptidomimetic for Brain Delivery. Angewandte Chemie. 128(2). 582–585. 9 indexed citations
12.
Morales, M.L González, Enrique J. Arenas, Jelena Urosevic, et al.. (2014). RARRES 3 suppresses breast cancer lung metastasis by regulating adhesion and differentiation. EMBO Molecular Medicine. 6(7). 865–881. 60 indexed citations
13.
Urosevic, Jelena, Xabier García‐Albéniz, Evarist Planet, et al.. (2014). Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH. Nature Cell Biology. 16(7). 685–694. 114 indexed citations
14.
Fluck, Mariano F. Zacarías, Kim Pedersen, Josep Lluís Parra-Palau, et al.. (2013). Constitutive HER2 Signaling Promotes Breast Cancer Metastasis through Cellular Senescence. Cancer Research. 73(1). 450–458. 77 indexed citations
15.
Soria‐Valles, Clara, Ana Gutiérrez‐Fernández, Marc Guiu, et al.. (2013). The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21. Oncogene. 33(23). 3054–3063. 65 indexed citations
16.
García, Marta, Roberto Vélez, Cleofé Romagosa, et al.. (2013). Cyclooxygenase‐2 inhibitor suppresses tumour progression of prostate cancer bone metastases in nude mice. British Journal of Urology. 113(5b). E164–77. 19 indexed citations
17.
Pavlović, Milica, Anna Arnal Estape, Jelena Urosevic, et al.. (2012). Identification of NOG as a Specific Breast Cancer Bone Metastasis-supporting Gene. Journal of Biological Chemistry. 287(25). 21346–21355. 55 indexed citations
18.
Estape, Anna Arnal, M.L González Morales, Marc Guiu, et al.. (2010). HER2 Silences Tumor Suppression in Breast Cancer Cells by Switching Expression of C/EBPβ Isoforms. Cancer Research. 70(23). 9927–9936. 35 indexed citations
19.
Blanc, Pierre, et al.. (1994). [Gastric metastasis complicating the course of lobular adenocarcinoma of the breast in a male patient].. PubMed. 23(33). 1539–1539. 1 indexed citations
20.
Delsol, G, et al.. (1979). Leukoerythroblastosis and cancer frequency, prognosis, and physiopathologic significance. Cancer. 44(3). 1009–1013. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026